Loading company…
Quantapore Inc. develops nanopore-based analytical platforms for direct single-molecule protein analysis in research.
Founded in 2009 and based in Menlo Park, US, Quantapore builds massively parallel tools that analyze single protein molecules, aimed at proteomics and genomics research by academic institutions, biotechnology companies and pharmaceutical firms. Revenue comes from direct sales of its analytical tools and ongoing service agreements. The company has raised USD 15.55 mn in total, with its most recent investment on June 25, 2018 led by Northern Light Venture Capital, and has completed 4 deals. Christian Dennstedt is the founder and Martin Huber is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in